share_log

海特生物(300683.SZ):注射用盐酸罗沙替丁醋酸酯、己酮可可碱注射液拟中选全国药品集采

Wuhan Hiteck Biological Pharma (300683.SZ): Injection of rohitidine hydrochloride acetate and ketoconazole injection is expected to be selected for the national Pharmaceutical centralized procurement.

Zhitong Finance ·  Dec 13 00:38

Wuhan Hiteck Biological Pharma (300683.SZ) announced that the company participated in the tenth batch of national centralized Pharmaceutical procurement organized by the national organization.

According to the announcement by Zhitong Finance APP, Wuhan Hiteck Biological Pharma (300683.SZ) announced that the company participated in the tenth batch of national centralized Pharmaceutical procurement organized by the national organization. According to the public notice of the proposed selection results for national centralized Pharmaceutical procurement released by the joint procurement office, the company’s products, injectable hydrochloride rosiglitazone acetate and hexylmethylsugar injection, are proposed to be selected for this centralized procurement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment